BC Week In Review | Dec 15, 2017
Clinical News

FDA approves Sanofi's Admelog for diabetes

Sanofi (Euronext:SAN; NYSE:SNY) said FDA approved an NDA for Admelog insulin lispro injection to improve blood sugar control in adults with Type II diabetes and in patients three years and older with Type I diabetes....
Items per page:
1 - 1 of 1